Application

PYRUKYND

Agios Pharmaceuticals, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90768935
Filing Date: 06/11/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90768935
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\907\689\90768935\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT PYRUKYND
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) purple, fuchsia, chartreuse and turquoise is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of four check designs joined at their bottoms, forming a stylized starburst shape, in the colors purple, fuchsia, chartreuse, and turquoise, above and to the left of the word pyrukynd in stylized purple lettering.
PIXEL COUNT ACCEPTABLE NO
PIXEL COUNT 950 x 331
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Agios Pharmaceuticals, Inc.
*MAILING ADDRESS 8 Sidney Street
*CITY Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02139-4169
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and/or alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
ACTIVE PRIOR REGISTRATION(S) The applicant claims ownership of active prior U.S. Registration Number(s) 6302036.
ATTORNEY INFORMATION
NAME Michael A. Lisi
ATTORNEY DOCKET NUMBER 232.026075
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Bridge Intellectual Property Services PLLC
STREET 23716 Woodward Avenue
CITY Pleasant Ridge
STATE Michigan
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 48069-1130
PHONE 248-284-4091
FAX 248-284-4091
EMAIL ADDRESS info@bridgeip.net
OTHER APPOINTED ATTORNEY Jennifer Sheehan Anderson
CORRESPONDENCE INFORMATION
NAME Michael A. Lisi
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE info@bridgeip.net
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Michael A. Lisi/
SIGNATORY'S NAME Michael A. Lisi
SIGNATORY'S POSITION Attorney of record, Michigan bar member
SIGNATORY'S PHONE NUMBER 248-284-4091
DATE SIGNED 06/11/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 05/31/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90768935
Filing Date: 06/11/2021

To the Commissioner for Trademarks:

MARK: PYRUKYND (stylized and/or with design, see mark)
The literal element of the mark consists of PYRUKYND. The color(s) purple, fuchsia, chartreuse and turquoise is/are claimed as a feature of the mark. The mark consists of four check designs joined at their bottoms, forming a stylized starburst shape, in the colors purple, fuchsia, chartreuse, and turquoise, above and to the left of the word pyrukynd in stylized purple lettering.
The applicant, Agios Pharmaceuticals, Inc., a corporation of Delaware, having an address of
      8 Sidney Street
      Cambridge, Massachusetts 02139-4169
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, sickle cell disease, pyruvate kinase deficiency (PKD), beta thalassemia and/or alpha thalassemia, genetically defined diseases affecting red blood cells, hereditary spherocytosis, hereditary elliptocytosis, dyserythropoiesis, hemolytic anemia, and other anemias
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 6302036.


The owner's/holder's proposed attorney information: Michael A. Lisi. Other appointed attorneys are Jennifer Sheehan Anderson. Michael A. Lisi of Bridge Intellectual Property Services PLLC, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      23716 Woodward Avenue
      Pleasant Ridge, Michigan 48069-1130
      United States
      248-284-4091(phone)
      248-284-4091(fax)
      info@bridgeip.net
The docket/reference number is 232.026075.
Michael A. Lisi submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Michael A. Lisi
       PRIMARY EMAIL FOR CORRESPONDENCE: info@bridgeip.net       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Michael A. Lisi/   Date: 06/11/2021
Signatory's Name: Michael A. Lisi
Signatory's Position: Attorney of record, Michigan bar member
Signatory's Phone Number: 248-284-4091
Signature method: Sent to third party for signature
Payment Sale Number: 90768935
Payment Accounting Date: 06/11/2021

Serial Number: 90768935
Internet Transmission Date: Fri Jun 11 11:53:40 ET 2021
TEAS Stamp: USPTO/BAS-XXXX:XXX:XXXX:XXXX:XXXX:XXX:XX
XX:XXXX-20210611115340387757-90768935-78
01952793bb6eaaba799c93fb2ce8e27b4a03f289
3fdbdab3ea14f1da3c9d1f-CC-53383359-20210
611110235282966

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed